Author:
Camaggi C. M.,Strocchi E.,Martoni A.,Zamagni C.,Cacciari N.,Robustelli della Cuna G.,Pavesi L.,Tedeschi M.,Silva A.,Pannuti F.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference22 articles.
1. Adlercreutz H, Nieminen U, Ervast HS (1974) A mass fragmentographic method for the determination of megestrol acetate in plasma and its application to studies on the plasma levels after administration of the progestin to patients with carcinoma corporis uteri. J Steroid Biochem 5:619?626
2. Adlercreutz H, Eriksen PB, Christensen MS (1983) Plasma concentrations of megestrol acetate and medroxyprogesterone acetate after single oral administration to healthy subjects. J Pharmacol Biomed Anal 1:153?162
3. Alexieva-Figusch J, Blankenstein MA, Hop WC, Klijn JG, Lamberts SW, Jong FH de, Docter R, Adlercreutz H, Gilse HA van (1984) Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effects. Eur J Cancer Clin Oncol 20:33?40
4. Bolton S (1990) Pharmaceutical statistics. Practical and clinical applications. Marcel Dekker, New York
5. Cruz JM, Muss HB, Brockschmidt JK, Evans GW (1990) Weight changes in women with metastatic breast cancer treated with megestrol acetate: comparison of standard versus high-dose therapy. Semin Oncol 17 [Suppl 9]: 63?67
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献